The ATR-Claspin-Chk1 pathway is critical for turning on the cellular response to DNA damage and replication stress. Five recent reports uncover new mechanisms controlling the recovery phase of the checkpoint response, and introduce crucial roles for Claspin, Rad17 phosphorylation and the ubiquitin proteasome pathway in Chk1 signaling.
Proper duplication of chromosomes is critical to cellular function and organismal development. Errors in this process can result in altered cellular pathways, aneuploidy, and disease. Organisms have consequently evolved elaborate control mechanisms to ensure the faithful transmission of their genetic material [1] .
Cells respond to DNA damage and replication blocks by activating the DNA-damage response network, a system which arrests the cell cycle and facilitates DNA repair. The machinery that senses damage and activates repair systems has been well studied. In contrast, far less is known about how the damage signal is terminated upon completion of DNA repair. In a series of elegant papers published recently in Current Biology, Molecular Cell and Cell [2] [3] [4] [5] [6] , several groups have uncovered important regulatory mechanisms that govern activation and turnover of Claspin -a critical mediator of the DNA-damage signaling system. Controlling Claspin abundance through the ubiquitin proteasome pathway appears to be at the heart of checkpoint recovery.
Linking Rad17 to the ATRClaspin-Chk1 Signaling Complex
The DNA-damage response pathway is composed of sensors, mediators, signal transducers and effectors [1] . However, because sensors form complexes with mediators and transducers, the lines between these different functionalities are somewhat blurred. The ATR-ATRIP protein kinase complex is a critical component of the cellular response to DNA damage and replication blocks [7] . ATR-ATRIP associates with single-stranded DNA at sites of damage with the help of replication protein A (RPA) and thus functions as a sensor of damage [8] . In concert, the Rad17 protein loads the DNA clamp Rad9-Rad1-Hus1 onto chromatin [9] . Rad17 binds chromatin independently of ATR, but in response to damage is phosphorylated by ATR at two sites (serine 635 and serine 645). These events culminate in the activation of Chk1 by ATR-ATRIP. Although it was clear that activation of Chk1 requires ATR, Rad17 and the Chk1 associated protein Claspin, the precise role of Rad17 phosphorylation and the relationship between Rad17 and Claspin was largely unknown [10] .
To address these questions, Wang et al. [6] replaced cellular Rad17 with a mutant form of Rad17, Rad17AA, which is defective in phosphorylation by ATR-ATRIP. They found that, although Rad17 phosphorylation is not required for chromatin binding or survival in culture, cells expressing Rad17AA displayed a shortened S-phase and increased rates of spontaneous chromosome breakage [6] . Rad17 phosphorylation was also found to be necessary for cell survival in the presence of hydroxyurea, a ribonucleotide reductase inhibitor and replication checkpoint activator, but not for survival after ultraviolet exposure. Thus, distinct damage networks differentially rely on Rad17 phosphorylation by ATR-ATRIP.
Chk1 is also required for cell survival in the presence of hydroxyurea, raising the question of whether Rad17 phosphorylation promotes Chk1 activation. Wang et al. [6] showed that, in response to hydroxyurea, Chk1 activation was reduced and prematurely terminated after hydroxyurea removal in Rad17AA-expressing cells. Interestingly, Claspin forms a complex with Rad17 in a manner that depends on Rad17 phosphorylation. Moreover, phosphorylation of Claspin was also blocked in Rad17AA-expressing cells.
Taken together, these data are consistent with a model in which ATR-ATRIP phosphorylation of Rad17 promotes ATR phosphorylation of Claspin, possibly via a Claspin-Rad17 complex. This presumably promotes Chk1 recruitment to Claspin, and ultimately Chk1 activation by ATR. This model is consistent with the observation that Rad17 phosphorylation is required to maintain Chk1 activation during the early periods of recovery from hydroxyurea treatment.
Claspin Degradation Turns off the Checkpoint
Once damaged DNA has been repaired, cells must turn off the checkpoint and reenter the cell cycle. The mechanisms of checkpoint termination are poorly understood, but three groups [2, 4, 5] have now identified a central role for the ubiquitin proteasome pathway in controlling recovery from the replication checkpoint, with Claspin as the primary target. Because replication stress likely occurs even during unperterbed cell cycles, it is not surprising that this mechanism functions even in the absence of exogenous mutagens.
Two different approaches were used to link Claspin to the ubiquitin proteasome pathway. Peschiaroli et al. [4] used a new proteomicbased substrate-capture approach to find novel targets of the E3 ubiquitin ligase SCF b-TRCP . This E3 has previously been implicated in the control of multiple cell-cycle events, through ubiquitination of the negative mitotic regulators Wee1 and Emi1, and also of the positive cell-cycle regulator Cdc25A [11] . In response to DNA damage, Chk1 promotes Cdc25A ubiquitination by SCF b-TRCP [12, 13] . Claspin was found to associate with b-TRCP, the substrate receptor of this E3 [4] . This association required a canonical b-TRCP phosphodegron (DpSGFXpS, where F is a hydrophobic residue and pS is phosphoserine) in the Claspin amino terminus.
Taking an alternative approach, Mailand et al. [5] and Mamely et al.
[2] examined whether, like Chk1, Claspin levels might be cell cycle regulated. Indeed, they found that Claspin levels were high in S-phase, and low during prophase, mitosis and G1, paralleling the established Wee1 pattern. Through the identification of a candidate b-TRCP phosphodegron in Claspin, Mailand et al. [5] and Mamely et al. [2] were able to finger SCF b-TRCP as a potential E3 for Claspin. All three groups [2, 4, 5] found that depletion of b-TRCP by RNA interference stabilized Claspin, and that phosphodegron mutation stabilized Clapsin during G2, when it is normally degraded. Moreover, Claspin turnover either in asynchronous cells or during checkpoint recovery was blocked by the proteasome inhibitor MG132, implicating the ubiquitin proteasome pathway [2, 4, 5] .
What triggers Claspin degradation, either in G2 or during recovery from checkpoint arrest, and how is this trigger regulated? All three groups [2, 4, 5] identified Plk1 as a kinase critical for Claspin destruction, and Plk1 was shown to promote Claspin ubiquitination by SCF b-TRCP in vitro [4, 5] . Plk1 has numerous roles during mitosis and cytokinesis, and has recently been shown to generate phosphodegrons on b-TRCP targets prior to mitotic entry [11, [14] [15] [16] . Degradation of these proteins occurs during G2, paralleling the pattern found for Claspin. Indeed, previous studies indicated that Plk1 is required for recovery of cells from G2 DNA-damage arrest [17] , and that Plk1 is inhibited in response to DNA damage [18] , by an unknown mechanism. Further studies are required to understand how Plk1 is activated during G2, and how it is targeted to Claspin. Such events may be prevented by Chk1, which stabilizes Claspin during S-phase.
What are the consequences of failing to turn off Claspin? Expression of Claspin mutants lacking the phosphodegron, which can not be ubiquitinated by b-TRCP, delays cell-cycle resumption after DNA damage or replication stress [2, 4, 5] . Stabilized Claspin mutants delay cell-cycle resumption because of the resulting prolonged activation of Chk1. Thus, destruction of Claspin is a critical step in the disassembly of the DNA-damage checkpoint signaling network, at least in human tissue culture cells. In Xenopus, Plk1 promotes dissociation of Claspin from chromatin [19] . Further studies are required to determine whether the conserved b-TRCP phosphodegron in Xenopus Claspin is used to control its turnover after chromatin release. Likewise, it is unclear whether MRC1 [20] , the yeast version of Claspin, is regulated similarly, as yeast lack an obvious b-TRCP ortholog and MRC1 does not have a canonical b-TRCP phosphodegron.
Buffering Claspin against Premature Degradation
Given the critical role of Claspin degradation in Chk1 inactivation, the question arises as to how cells prevent inappropriate Claspin degradation. The answer may lie in the identification of a deubiquitinating enzyme, USP28, which promotes removal of ubiqutin chains from several checkpoint proteins, including Claspin [3] . USP28 was identified as a protein associated with the checkpoint mediator protein 53BP1. Disruption of USP28 function renders cells resistant to ionizing radiation-induced apoptosis. Analysis of a host of checkpoint proteins revealed that several, including Chk2 and mediators such as Claspin, are dramatically destabilized in the absence of USP28 after DNA damage, suggesting that USP28 normally protects these proteins from degradation during checkpoint activation. Claspin is a bona fide USP28 substrate, as Claspin deubiquitination by USP28 could also be reconstituted in vitro. In response to ionizing radiation, USP28 is phosphorylated in an ATM-dependent manner, potentially providing a mechanism for control of USP28 activity [3] .
Outstanding Questions
While this work provides new insights into how signaling through the ATR-Claspin-Chk1 pathway is regulated, several questions remain. Is Claspin the primary protein whose destruction during recovery allows for cell-cycle progression? In this regard, a number of checkpoint mediators and regulators are unstable proteins whose destruction may be required for re-instating the cell-cycle machinery. How is Plk1 activity controlled during S-phase to ensure that Claspin is not prematurely degraded? One possibility is that Rad17 and/or Chk1 sequesters Claspin, and thereby blocks access to Plk1. Alternatively, additional kinases may be important for priming Claspin for phosphorylation by Plk1, although the finding that Plk1 can promote SCF b-TRCPdependent ubiqutination of Claspin in vitro may argue against this. Understanding how Plk1 is regulated during S-phase will be necessary for distinguishing between these possibilities. Finally, the antagonistic relationship between USP28 and SCF b-TRCP with respect to controlling Claspin levels may signal a theme common to proteins involved in cell-cycle transitions: regulatory inputs into opposing systems creates switch-like behavior that governs cell-cycle transitions.
